Stay updated on Gilteritinib vs Midostaurin in AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib vs Midostaurin in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib vs Midostaurin in AML Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study history now includes 'No longer looking for participants,' signaling that enrollment for this trial has ended. Additionally, the record version was updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T00:15:22.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The history page shows a new revision entry (v3.5.5), superseding the previous revision (v3.5.4) in the study record history.
    Difference
    0.1%
    Check dated 2026-06-05T22:04:47.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    A new release revision v3.5.4 was added to the Record History. The previous revision v3.5.3 was removed.
    Difference
    0.1%
    Check dated 2026-05-15T15:54:44.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page footer’s site revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a platform release without changing the clinical trial information shown.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:17.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The history shows a new revision labeled v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:15.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision v3.5.0 has been added to the record history, replacing the previous revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:46.000Z thumbnail image

Stay in the know with updates to Gilteritinib vs Midostaurin in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib vs Midostaurin in AML Clinical Trial page.